home / stock / vlrx / vlrx news

VLRX News and Press, Valeritas Holdings From 09/17/19

Stock Information
Company Name: Valeritas Holdings
Stock Symbol: VLRX
Market: NASDAQ
Website: valeritas.com
Menu
VLRX VLRX Quote VLRX Short VLRX News VLRX Articles VLRX Message Board
Get VLRX Alerts

News, Short Squeeze, Breakout and More Instantly...
VLRX - Valeritas Announces Poster Presentation of Preclinical h-Patch(TM) Apomorphine Study at the Global Experts Meeting on Frontiers in Alzheimer's Disease & Dementia

BRIDGEWATER, N.J., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today a poster presentat...
VLRX - AU, HMY among premarket gainers

Sintx Technologies (NASDAQ: SINT ) +53% . More news on: Sintx Technologies, Inc., Valeritas Holdings, Inc., MDJM Ltd., Stocks on the move, Read more ...

VLRX - Valeritas Holdings up 41% premarket on positive h-Patch CBD data

Nano cap Valeritas Holdings (NASDAQ: VLRX ) is up  41%  premarket on average volume in reaction to positive results from a pharmacokinetic study demonstrating "rapid and robust" absorption and distribution of 40 mg of cannabidiol (CBD) over 24 hours with its h-Patch technology. ...

VLRX - Valeritas Presents Positive CBD h-Patch(TM) Data at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit

BRIDGEWATER, N.J., Sept. 12, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today positive data from...
VLRX - Valeritas Announces Oral Presentation of Preclinical h-Patch(TM) CBD Study at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit

BRIDGEWATER, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device , which uses its proprietary h-Patch™ technology , announced today an oral presentati...

VLRX - Valeritas up 10% premarket on positive V-Go performance with regular insulin

Nano cap Valeritas Holdings (NASDAQ: VLRX ) is up  10%  premarket on modest volume in reaction to the results of an investigator-initiated study  comparing the delivery of U-100 regular human insulin with the V-Go device with rapid acting insulin with V-Go in type 2 diabeti...

VLRX - Clinical Trial Evaluating Delivery of Regular Human Insulin vs. Rapid Acting Insulin Delivered by Valeritas' V-Go® Meets Primary A1c Endpoint

BRIDGEWATER, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that a ra...
VLRX - Valeritas Holdings' (VLRX) CEO John Timberlake on Q2 2019 Results - Earnings Call Transcript

Valeritas Holdings, Inc. (VLRX) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Greg Chodaczek – Gilmartin Group John Timberlake – President and Chief Executive Officer Erick Lucera – Chief Financial Officer Jessica Barnes &#...

VLRX - Valeritas EPS beats by $0.16, beats on revenue

Valeritas (NASDAQ: VLRX ): Q2 GAAP EPS of -$2.73 beats by $0.16 . More news on: Valeritas Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

VLRX - Valeritas Announces Second Quarter 2019 Financial Results

BRIDGEWATER, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go ® Wearable Insulin Delivery device , a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced f...
Previous 10 Next 10